The Minister for Public Health has not held any recent discussions on this subject.<\/p>
<\/p>
Promoting good mental health is a key strategic objective of Public Health England\u2019s (PHE) public mental health programme, alongside preventing mental illness and improving the lives of those living with mental illness. PHE is working with the National Health Service, local authorities and other partners to help more people have good mental health, improve the physical health and wellbeing of those with mental illness, and ensure few people as possible suffer avoidable harm.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1201", "label" : {"_value" : "Biography information for Alistair Burt"} } , "answeringMemberConstituency" : {"_value" : "North East Bedfordshire"} , "answeringMemberPrinted" : {"_value" : "Alistair Burt"} , "dateOfAnswer" : {"_value" : "2016-02-02", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-02-02T11:31:27.373Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-01-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what recent discussions the Minister for Public Health has had with mental health charities on the importance of public mental health interventions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3953", "label" : {"_value" : "Biography information for Jason McCartney"} } , "tablingMemberConstituency" : {"_value" : "Colne Valley"} , "tablingMemberPrinted" : [{"_value" : "Jason McCartney"} ], "uin" : "24241"} , {"_about" : "http://data.parliament.uk/resources/385852", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/385852/answer", "answerText" : {"_value" : "
NHS Blood and Transplant launched a new United Kingdom-wide organ donation and transplantation strategy in July 2013. Taking Organ Transplantation to 2020<\/em> sets out the action necessary to increase organ donation and transplant rates building on the significant increase in donor and transplant rates since 2008. It is vital that all potential donors are identified and referred to the specialist donation team. The strategy recognises that commissioners should keep the demand for intensive care beds under review to ensure that intensive care capacity is not a barrier to donation.<\/p> <\/p> <\/p> <\/p> There were 10.6 adult critical care, paediatric intensive care and neonatal intensive care beds per 100,000 population in England in May 2015. The numbers of such beds in the rest of the United Kingdom is a matter for the devolved administrations.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-07-03", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "4316"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-07-03T11:48:51.87Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-06-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Transplant Surgery: Intensive Care"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what recent assessment he has made of the effect of the number of intensive care unit beds in the UK on the number of transplants that per capita the NHS can provide.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3953", "label" : {"_value" : "Biography information for Jason McCartney"}
}
, "tablingMemberConstituency" : {"_value" : "Colne Valley"}
, "tablingMemberPrinted" : [{"_value" : "Jason McCartney"}
], "uin" : "4312"}
, {"_about" : "http://data.parliament.uk/resources/385854", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/385854/answer", "answerText" : {"_value" : " NHS Blood and Transplant launched a new United Kingdom-wide organ donation and transplantation strategy in July 2013. Taking Organ Transplantation to 2020<\/em> sets out the action necessary to increase organ donation and transplant rates building on the significant increase in donor and transplant rates since 2008. It is vital that all potential donors are identified and referred to the specialist donation team. The strategy recognises that commissioners should keep the demand for intensive care beds under review to ensure that intensive care capacity is not a barrier to donation.<\/p> <\/p> <\/p> <\/p> There were 10.6 adult critical care, paediatric intensive care and neonatal intensive care beds per 100,000 population in England in May 2015. The numbers of such beds in the rest of the United Kingdom is a matter for the devolved administrations.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-07-03", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "4312"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-07-03T11:48:51.967Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-06-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Intensive Care: Hospital Beds"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many intensive care unit beds there are per capita in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3953", "label" : {"_value" : "Biography information for Jason McCartney"}
}
, "tablingMemberConstituency" : {"_value" : "Colne Valley"}
, "tablingMemberPrinted" : [{"_value" : "Jason McCartney"}
], "uin" : "4316"}
, {"_about" : "http://data.parliament.uk/resources/227878", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/227878/answer", "answerText" : {"_value" : " We are seeking to reach a positive conclusion to the negotiations with GlaxoSmithKline for supply of the meningococcal B (MenB) vaccine, Bexsero® <\/sup>at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, as soon as possible.<\/p> <\/p> <\/p> <\/p> The Department has had a number of meetings with the manufacturer and is continuing to meet.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-03-24", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "227878"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-03-24T17:25:29.033Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Meningitis: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 11 March 2015 to Question 226346, when he expects negotiations with GlaxoSmithKline on the meningitis B vaccine to be concluded.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3953", "label" : {"_value" : "Biography information for Jason McCartney"}
}
, "tablingMemberConstituency" : {"_value" : "Colne Valley"}
, "tablingMemberPrinted" : [{"_value" : "Jason McCartney"}
], "uin" : "227877"}
, {"_about" : "http://data.parliament.uk/resources/227879", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/227879/answer", "answerText" : {"_value" : " We are seeking to reach a positive conclusion to the negotiations with GlaxoSmithKline for supply of the meningococcal B (MenB) vaccine, Bexsero® <\/sup>at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, as soon as possible.<\/p> <\/p> <\/p> <\/p> The Department has had a number of meetings with the manufacturer and is continuing to meet.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-03-24", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "227877"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-03-24T17:25:29.127Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Meningitis: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking with officials of his Department to expedite negotiations with GlaxoSmithKline on the meningitis B vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3953", "label" : {"_value" : "Biography information for Jason McCartney"}
}
, "tablingMemberConstituency" : {"_value" : "Colne Valley"}
, "tablingMemberPrinted" : [{"_value" : "Jason McCartney"}
], "uin" : "227878"}
, {"_about" : "http://data.parliament.uk/resources/170714", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/170714/answer", "answerText" : {"_value" : " Consultation both with clinical commissioning groups (CCGs) and the wider public concerning the transfer of commissioning responsibility of Renal Dialysis from NHS England to CCGs is ongoing.<\/p> <\/p> <\/p> <\/p> The Department has launched a public consultation which closes on 9 January 2015. The consultation considers how to transfer commissioning responsibility and what would need to happen to ensure a smooth transition and maintain both service standards and patient safety. All CCGs are invited to comment on the proposed changes.<\/p> <\/p> <\/p> <\/p>